Triazolopyridine derivatives as p38 MAP kinase inhibitors

Details for Australian Patent Application No. 2010215261 (hide)

Owner Pulmagen Therapeutics (Inflammation) Limited.

Inventors Finch, Harry; Montana, John; Van Niel, Monique Bodil; Woo, Chi-Kit; Knight, Jamie; Waszkowycz, Bohdan

Agent Golja Haines & Friend

Pub. Number AU-A-2010215261

PCT Pub. Number WO2010/094956

Priority 0902651.9 17.02.09 GB; 0908069.8 11.05.09 GB

Filing date 16 February 2010

Wipo publication date 26 August 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/094956 Priority application(s): WO2010/094956

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215262-Fluid communication path

2010215256-Tooth construction